Clarametyx Biosciences Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Series A1
- Latest Deal Amount
-
$33M
- Investors
-
9
Clarametyx Biosciences General Information
Description
Developer of immune-facilitated biologic therapies designed to fight life-threatening infections. The company's novel technology platform targets the protective barrier around bacteria through biological therapies, enabling healthcare professionals to target the challenging infections fueled by biofilms and reduce antibiotic resistance.
Contact Information
Website
www.clarametyx.comCorporate Office
- Energy Advancement & Innovation Center
- 2281 Kenny Road, Suite 410
- Columbus, OH 43210
- United States
Corporate Office
- Energy Advancement & Innovation Center
- 2281 Kenny Road, Suite 410
- Columbus, OH 43210
- United States
Clarametyx Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series A1) | 17-Jul-2025 | $33M | Completed | Clinical Trials - Phase 2 | ||
| 4. Grant | 01-Jan-2021 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC (Series A) | 25-Jan-2021 | Completed | Pre-Clinical Trials | |||
| 2. Grant | 18-Nov-2020 | $14.3M | $3M | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 01-May-2020 | $3M | $3M | Completed | Startup |
Clarametyx Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Clarametyx Biosciences Comparisons
Industry
Financing
Details
Clarametyx Biosciences Competitors (97)
One of Clarametyx Biosciences’s 97 competitors is Shinobi Therapeutics, a Venture Capital-Backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Shinobi Therapeutics | Venture Capital-Backed | South San Francisco, CA | ||||
| Trellis Bioscience | Venture Capital-Backed | Redwood City, CA | ||||
| Aro Biotherapeutics | Venture Capital-Backed | Philadelphia, PA | ||||
| Cristal Therapeutics | Venture Capital-Backed | Maastricht, Netherlands | ||||
| Enterprise Therapeutics | Venture Capital-Backed | Brighton, United Kingdom |
Clarametyx Biosciences Signals
Clarametyx Biosciences Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Candice Venture Fund | Venture Capital | Minority | ||
| CincyTech | Venture Capital | Minority | ||
| Kineticos Life Sciences Management | Venture Capital | Minority | ||
| JobsOhio Ventures | Venture Capital | Minority | ||
| Nationwide Children's Hospital | VC-Backed Company | Minority |
Clarametyx Biosciences FAQs
-
When was Clarametyx Biosciences founded?
Clarametyx Biosciences was founded in 2019.
-
Where is Clarametyx Biosciences headquartered?
Clarametyx Biosciences is headquartered in Columbus, OH.
-
What is the size of Clarametyx Biosciences?
Clarametyx Biosciences has 14 total employees.
-
What industry is Clarametyx Biosciences in?
Clarametyx Biosciences’s primary industry is Drug Discovery.
-
Is Clarametyx Biosciences a private or public company?
Clarametyx Biosciences is a Private company.
-
What is the current valuation of Clarametyx Biosciences?
The current valuation of Clarametyx Biosciences is .
-
What is Clarametyx Biosciences’s current revenue?
The current revenue for Clarametyx Biosciences is .
-
How much funding has Clarametyx Biosciences raised over time?
Clarametyx Biosciences has raised $44M.
-
Who are Clarametyx Biosciences’s investors?
Candice Venture Fund, CincyTech, Kineticos Life Sciences Management, JobsOhio Ventures, and Nationwide Children's Hospital are 5 of 9 investors who have invested in Clarametyx Biosciences.
-
Who are Clarametyx Biosciences’s competitors?
Shinobi Therapeutics, Trellis Bioscience, Aro Biotherapeutics, Cristal Therapeutics, and Enterprise Therapeutics are some of the 97 competitors of Clarametyx Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process